RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, held its annual meeting of stockholders on June 30, 2009 at which Douglas Swirsky was newly elected to serve on the Board of Directors. At the annual meeting, stockholders also re-elected seven incumbent directors to continue to serve on the Board.
